Skip to search formSkip to main contentSkip to account menu

XL184

An orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. XL184 strongly binds to and… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
Review
2008
Nature Reviews Drug Discovery 7, 547–549 (July 2008) | doi:10.1038/nrd2633 This article stated that: “Clinicians are looking at…